These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler. Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutic approaches for the treatment of facial aging]. Gauglitz GG; Podda M Hautarzt; 2015 Oct; 66(10):738-43. PubMed ID: 26349682 [TBL] [Abstract][Full Text] [Related]
6. Providing Optimal Rejuvenation to the Periocular Area Using Botulinum Toxin A Neuromodulators and Hyaluronic Acid Dermal Fillers. Varga R Plast Surg Nurs; 2019; 39(4):119-124. PubMed ID: 31790040 [TBL] [Abstract][Full Text] [Related]
7. Topical skin therapies in subjects undergoing full facial rejuvenation. Dayan SH; Bacos JT; Ho TT; Gandhi ND; Gutierrez-Borst S; Kalbag A J Cosmet Dermatol; 2019 Jun; 18(3):798-805. PubMed ID: 31033162 [TBL] [Abstract][Full Text] [Related]
8. New Uses of AbobotulinumtoxinA in Aesthetics. Schlessinger J; Gilbert E; Cohen JL; Kaufman J Aesthet Surg J; 2017 May; 37(suppl_1):S45-S58. PubMed ID: 28388720 [TBL] [Abstract][Full Text] [Related]
9. Repeated Full-Face Aesthetic Combination Treatment With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin-Boosting Hyaluronic Acid After Monotherapy With AbobotulinumtoxinA or Hyaluronic Acid Filler. Cartier H; Hedén P; Delmar H; Bergentz P; Skoglund C; Edwartz C; Norberg M; Kestemont P Dermatol Surg; 2020 Apr; 46(4):475-482. PubMed ID: 31592825 [TBL] [Abstract][Full Text] [Related]
10. Periorbital Rejuvenation: Overview of Nonsurgical Treatment Options. Glaser DA; Kurta A Facial Plast Surg Clin North Am; 2016 May; 24(2):145-52. PubMed ID: 27105800 [TBL] [Abstract][Full Text] [Related]
11. Global Aesthetics Consensus: Hyaluronic Acid Fillers and Botulinum Toxin Type A-Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations. Sundaram H; Liew S; Signorini M; Vieira Braz A; Fagien S; Swift A; De Boulle KL; Raspaldo H; Trindade de Almeida AR; Monheit G; Plast Reconstr Surg; 2016 May; 137(5):1410-1423. PubMed ID: 27119917 [TBL] [Abstract][Full Text] [Related]
12. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes. Carruthers J; Carruthers A; Monheit GD; Davis PG Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457 [TBL] [Abstract][Full Text] [Related]
13. Consensus Recommendations for Combined Aesthetic Interventions in the Face Using Botulinum Toxin, Fillers, and Energy-Based Devices. Carruthers J; Burgess C; Day D; Fabi SG; Goldie K; Kerscher M; Nikolis A; Pavicic T; Rho NK; Rzany B; Sattler G; Sattler S; Seo K; Werschler WP; Carruthers A Dermatol Surg; 2016 May; 42(5):586-97. PubMed ID: 27100962 [TBL] [Abstract][Full Text] [Related]
14. Advances in facial rejuvenation: botulinum toxin type a, hyaluronic acid dermal fillers, and combination therapies--consensus recommendations. Carruthers JDA; Glogau RG; Blitzer A; Plast Reconstr Surg; 2008 May; 121(5 Suppl):5S-30S. PubMed ID: 18449026 [TBL] [Abstract][Full Text] [Related]
15. Retention Rates Among Patients Undergoing Multimodal Facial Rejuvenation Treatment Versus a Single Monotherapy in Cosmetic Dermatology Practices. Gregory A; Humphrey S; Chunharas C; Ogilvie P; Fabi SG Dermatol Surg; 2020 Feb; 46(2):240-246. PubMed ID: 31453910 [TBL] [Abstract][Full Text] [Related]
16. Maximizing Panfacial Aesthetic Outcomes: Findings and Recommendations From the HARMONY Study. Kaminer MS; Cohen JL; Shamban A; Werschler WP; Shumate GT; Drinkwater A; Gallagher CJ Dermatol Surg; 2020 Jun; 46(6):810-817. PubMed ID: 31834076 [TBL] [Abstract][Full Text] [Related]